Qiming Kou

机构：Sichuan University, Sichuan Cancer Hospital, Jilin Medical University · ORCID：0000-0002-8534-881X

发表论文 12 篇 · 总被引 122 次 · h-index 7

代表论文

• DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis (2023 · Cellular Oncology · 被引 26)
• Ultrasensitive detection of circulating tumor cells in clinical blood samples by a three-dimensional network nanovehicle-based aptasensor platform (2023 · Sensors and Actuators B Chemical · 被引 20)
• DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma (2024 · Biochemical Pharmacology · 被引 17)
• Alkannin triggered apoptosis and ferroptosis in gastric cancer by suppressing lipid metabolism mediated by the c-Fos/SREBF1 axis (2025 · Phytomedicine · 被引 16)
• ZNF32 prevents the activation of cancer‐associated fibroblasts through negative regulation of TGFB1 transcription in breast cancer (2023 · The FASEB Journal · 被引 16)
• DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation (2025 · Signal Transduction and Targeted Therapy · 被引 12)